Salmonella Newport Outbreak Investigated; Heart Pump, Bone Cement Supply Issues

The FDA is currently investigating a new outbreak of Salmonella Newport infections, with seven confirmed cases but the source remains undetermined. In related news, investigations continue into previous outbreaks of infant botulism and Listeria, and an Executive Summary was released regarding a Salmonella Richmond outbreak traced to moringa leaf powder. Healthcare providers are also alerted to a potential issue with Abiomed Impella heart pump purge cassettes, which could lead to pump failure. Meanwhile, in the UK, a bone cement supply disruption threatens to delay elective surgeries. ## Latest Update The NHS's main provider of bone cement, Heraeus Medical, experienced a packaging fault, halting production and causing an expected supply disruption of at least two months. The Department of Health and Social Care is working to secure alternative supplies to minimize the impact on elective care. ## Timeline * **2026-02-25:** The FDA alerted healthcare providers to a potential issue with Abiomed Impella Generation 1 Purge Cassettes, citing an increased risk of purge leaks. * **2026-02-25:** Heraeus Medical, the NHS's main provider of bone cement, suffered a packaging fault, causing a supply disruption of at least two months. * **2026-02-12:** The FDA announced an investigation into a new outbreak of Salmonella Newport infections with seven confirmed cases. ## What to Watch * **Source Identification:** Monitor for updates on the source of the Salmonella Newport outbreak and any potential recalls. * **Medical Supply Chain:** Track the resolution of the bone cement supply issue in the UK and its impact on surgical wait times. * **Mitigation Strategies:** Follow the FDA's evaluation of the Impella heart pump purge cassette issue and any mitigation strategies for healthcare providers.